Back
CRISPR Therapeutics AG 10K Form
Sell
33
CRSP
CRISPR Therapeutics AG
Last Price:
55.79
Seasonality Move:
25.22%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-06 | 10Q | CRSP/CRISPR Therapeutics AG Quarterly |
| 2023-08-07 | 10Q | CRSP/CRISPR Therapeutics AG Quarterly |
| 2023-05-08 | 10Q | CRSP/CRISPR Therapeutics AG Quarterly |
| 2022-11-01 | 10Q | CRSP/CRISPR Therapeutics AG Quarterly |
| 2022-08-08 | 10Q | CRSP/CRISPR Therapeutics AG Quarterly |
| 2022-05-09 | 10Q | CRSP/CRISPR Therapeutics AG Quarterly |
Receive CRSP News And Ratings
See the #1 stock for the next 7 days that we like better than CRSP
CRSP Financial Statistics
Sales & Book Value
| Annual Sales: | $370M |
|---|---|
| Cash Flow: | $-96.81M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $23.52 |
| Price / Book: | 2.53 |
Profitability
| EPS (TTM): | -1.93000 |
|---|---|
| Net Income (TTM): | $-153.61M |
| Gross Margin: | $239.75M |
| Return on Equity: | -8.39% |
| Return on Assets: | -6.98% |
CRISPR Therapeutics AG Earnings Forecast
Key CRISPR Therapeutics AG Financial Ratios
- The Gross Profit Margin over the past 3 years for CRSP is 64.80%.
- The Selling, General & Administrative Expenses for CRSP have been equal to 20.58% of Gross Profit Margin.
- The Research & Development expenses have been 104.68% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of CRSP is -41.52% of Total Revenues.
- Per Share Earnings over the last 10 years have been positive in 4 years.
CRISPR Therapeutics AG Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CRSP |
| CUSIP: | H17182 |
| Website: | crisprtx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 17.54 |
| Quick Ratio: | 17.41 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CRSP Technical Analysis vs Fundamental Analysis
Sell
33
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy or a Sell?
-
CRISPR Therapeutics AG stock is rated a Sell
The current CRISPR Therapeutics AG [CRSP] share price is $56.14. The Score for CRSP is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.